{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:55:27Z","timestamp":1784336127340,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1053\/j.seminoncol.2016.02.017","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T02:39:29Z","timestamp":1456195169000},"page":"395-400","source":"Crossref","is-referenced-by-count":27,"title":["Cutaneous manifestations of multiple myeloma and other plasma cell proliferative disorders"],"prefix":"10.1053","volume":"43","author":[{"given":"Manisha","family":"Bhutani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Schnebelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Alapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Z.","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2016.02.017_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archderm.139.4.475","article-title":"Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases","volume":"139","author":"Requena","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib2","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach","volume":"29","author":"Blade","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","volume":"97","author":"Usmani","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.172.3988.1150","article-title":"Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses","volume":"172","author":"Glenner","year":"1971","journal-title":"Science"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.017_bib5","first-page":"89","article-title":"Primary localized cutaneous nodular amyloidosis of the feet: a case report and review of the literature","volume":"93","author":"Ritchie","year":"2014","journal-title":"Cutis"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(88)70001-8","article-title":"Amyloid and amyloidosis","volume":"18","author":"Breathnach","year":"1988","journal-title":"J Am Acad Dermatol."},{"key":"10.1053\/j.seminoncol.2016.02.017_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00005792-197507000-00001","article-title":"Amyloidosis: review of 236 cases","volume":"54","author":"Kyle","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000247630","article-title":"Nail changes as the first sign of systemic amyloidosis","volume":"183","author":"Fanti","year":"1991","journal-title":"Dermatologica"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205919","article-title":"A systemic disease un\u2026suspected by physical examination","author":"Costa","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ajh.23828","article-title":"Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment","volume":"89","author":"Gertz","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib11","doi-asserted-by":"crossref","unstructured":"Fernandez de Larrea C, Verga L, et al. A practical approach to the diagnosis of systemic amyloidoses. Blood 2015;125(14):2239-44.","DOI":"10.1182\/blood-2014-11-609883"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.02.017_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rdc.2014.09.008","article-title":"Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances","volume":"41","author":"Ghetie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0190-9622(91)70168-2","article-title":"Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients","volume":"25","author":"Cohen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0190-9622(89)70023-2","article-title":"Chronic urticaria and macroglobulinemia (Schnitzler\u05f3s syndrome): report of two cases","volume":"20","author":"Janier","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaad.2012.04.027","article-title":"Clinical and histopathologic review of Schnitzler syndrome: the Mayo Clinic experience (1972-2011)","volume":"67","author":"Sokumbi","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment","volume":"37","author":"de Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.clindermatol.2006.07.011","article-title":"Scleromyxedema","volume":"24","author":"Cokonis Georgakis","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1523-1747.ep12543468","article-title":"Immunochemical analysis of the monoclonal paraprotein in scleromyxedema","volume":"70","author":"Kitamura","year":"1978","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2016.02.017_bib20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/BOR.0000000000000118","article-title":"Scleromyxedema","volume":"26","author":"Hummers","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ajh.22131","article-title":"Scleromyxedema and dermato-neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib","volume":"86","author":"Fett","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib22","first-page":"263","article-title":"Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature","volume":"9","author":"Sroa","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/diacare.6.2.189","article-title":"Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus","volume":"6","author":"Cole","year":"1983","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.017_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.rdc.2013.02.013","article-title":"Localized cutaneous fibrosing disorders","volume":"39","author":"Yaqub","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archderm.1981.01650090018016","article-title":"Monoclonal gammopathy in scleredema. Observations in three cases","volume":"117","author":"Kovary","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0781.2004.00106.x","article-title":"UVA-1 as a treatment for scleredema","volume":"20","author":"Janiga","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0190-9622(96)90129-2","article-title":"Cyclosporine in scleredema","volume":"35","author":"Mattheou-Vakali","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.0736-8046.2004.21325.x","article-title":"Dexamethasone pulse therapy for scleredema","volume":"21","author":"Dogra","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0190-9622(80)80189-7","article-title":"Necrobiotic xanthogranuloma with paraproteinemia","volume":"3","author":"Kossard","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2009.03912.x","article-title":"Necrobiotic xanthogranuloma","volume":"48","author":"Spicknall","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archderm.1992.01680110104016","article-title":"Necrobiotic xanthogranuloma","volume":"128","author":"Mehregan","year":"1992","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1053\/j.seminoncol.2016.02.017_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.det.2015.03.010","article-title":"Adult orbital xanthogranulomatous disease: a review with emphasis on etiology, systemic associations, diagnostic tools, and treatment","volume":"33","author":"Kerstetter","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib33","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1200\/JCO.2010.32.4921","article-title":"Necrobiotic xanthogranuloma associated with immunoglobulin m paraproteinemia in a patient with Waldenstrom macroglobulinemia","volume":"29","author":"Balagula","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archdermatol.2008.583","article-title":"Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation","volume":"145","author":"Wood","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib35","first-page":"678","article-title":"Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy","volume":"11","author":"Ghani","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00277-006-0231-0","article-title":"Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation","volume":"86","author":"Goede","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib37","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.34.6.712","article-title":"The Crow-Fukase syndrome: a study of 102 cases in Japan","volume":"34","author":"Nakanishi","year":"1984","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib39","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D\u05f3Souza","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-4632.2012.05648.x","article-title":"Cutaneous manifestations in patients with POEMS syndrome","volume":"52","author":"Miest","year":"2013","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2016.02.017_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ajh.23644","article-title":"POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Dispenzieri","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archdermatol.2010.100","article-title":"Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation","volume":"146","author":"Barete","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00005792-200301000-00005","article-title":"The AESOP (adenopathy and extensive skin patch overlying a plasmacytoma) syndrome: report of 4 cases of a new syndrome revealing POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome at a curable stage","volume":"82","author":"Lipsker","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jaad.2006.04.072","article-title":"Cutaneous mucinous angiomatosis as a presenting sign of bone plasmacytoma: a new case of (A)ESOP syndrome","volume":"55","author":"Rongioletti","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib45","first-page":"25","article-title":"Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome","volume":"5","author":"Farooq","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib46","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1600-0560.2007.00884.x","article-title":"The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies","volume":"35","author":"Rongioletti","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archdermatol.2011.26","article-title":"Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-lambda and IgA-kappa gammopathy following treatment of a nodal plasmacytoma","volume":"147","author":"New","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib48","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3324\/haematol.2011.054015","article-title":"Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study","volume":"97","author":"Kristinsson","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2016.02.017_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1067\/mjd.2003.180","article-title":"The spectrum of cutaneous disease in multiple myeloma","volume":"48","author":"Bayer-Garner","year":"2003","journal-title":"J Am Acad Dermatol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T19:56:51Z","timestamp":1536955011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775416000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0093775416000427"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.02.017","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}